[1]朱碧云,张 淳.Charlson合并症指数与急性心肌梗死患者院内死亡及长时住院的关系[J].医学信息,2023,36(22):63-67.[doi:10.3969/j.issn.1006-1959.2023.22.013]
　ZHU Bi-yun,ZHANG Chun.Relationship Between Charlson Comorbidity Index and In-hospital Mortality, Long-term Hospitalization in Patients with Acute Myocardial Infarction[J].Journal of Medical Information,2023,36(22):63-67.[doi:10.3969/j.issn.1006-1959.2023.22.013]
点击复制

Charlson合并症指数与急性心肌梗死患者院内死亡及长时住院的关系()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年22期
页码:
63-67
栏目:
论著
出版日期:
2023-11-15

文章信息/Info

Title:
Relationship Between Charlson Comorbidity Index and In-hospital Mortality, Long-term Hospitalization in Patients with Acute Myocardial Infarction
文章编号:
1006-1959（2023）22-0063-05
作者:
朱碧云; 张 淳
（首都医科大学附属北京地坛医院医学工程处，北京 100015）
Author(s):
ZHU Bi-yun; ZHANG Chun
(Department of Medical Engineering,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,China)
关键词:
Charlson合并症; 急性心肌梗死; 院内死亡; 长时住院
Keywords:
Charlson comorbidity; Acute myocardial infarction; In-hospital mortality; Long-term hospitalization
分类号:
R197
DOI:
10.3969/j.issn.1006-1959.2023.22.013
文献标志码:
A
摘要:
目的 分析Charlson合并症指数与急性心肌梗死（AMI）患者院内死亡及长时住院的关系。方法 选取北京某三甲医院2014-2016年2012例AMI住院患者，使用住院病案首页的出院诊断字段统计患者的Charlson合并症种类及数量，计算相应的Charlson合并症指数（CCI）评分。分析不同CCI评分的AMI患者院内死亡及长时住院（住院超过14 d）的差异，运用Logistic回归分析探索AMI患者院内死亡及长时住院的影响因素。结果 2012例AMI患者中，合并充血性心力衰竭的患者最多（57.46%），其次为糖尿病（不伴合并症）（35.88%）和脑血管疾病（17.25%）。164例（8.15%）患者发生院内死亡，其中44.51%有重度合并症（CCI≥3），而中度合并症（CCI=2）占26.22%，轻度合并症（CCI=1）占25.00%。402例（19.98%）住院时长超过14 d的患者中，重度、中度、轻度合并症患者分别占34.33%、26.87%和28.86%。Logistic回归分析显示，充血性心力衰竭、糖尿病（不伴合并症）、肾病是AMI患者院内死亡的独立影响因素，充血性心力衰竭、慢性肺部疾病、肾病是AMI患者长时住院的独立影响因素。结论 Charlson合并症指数对AMI患者院内死亡和住院时长有影响，利用CCI评分评价不同合并症具有一定可行性。
Abstract:
Objective To analyze the relationship between Charlson comorbidity index and in-hospital death, long-term hospitalization in patients with acute myocardial infarction (AMI). Methods From 2014 to 2016, a total of 2012 AMI patients of a third class hospital in Beijing were retrospectively screened as the study subjects. The types and number of Charlson complications were counted by using relevant fields on the first page of inpatient medical records, and the corresponding Charlson comorbidity index (CCI) scores were calculated to analyze the differences of in-hospital death and long-term hospitalization among AMI patients with different CCI scores. Logistic regression analysis was used to investigate the influencing factors of in-hospital death and long-term hospitalization in AMI patients.Results Among 2012 AMI patients, congestive heart failure was the most common (57.46%), followed by diabetes mellitus (without comorbidities) (35.88%) and cerebrovascular disease (17.25%). Among 164 patients (8.15%) who died in hospital, 44.51% had severe complications (CCI≥3), moderate complications (CCI=2) accounted for 26.22%, and mild complications (CCI=1) accounted for 25.00%. Among 402 patients (19.98%) hospitalized for more than 14 days, severe, moderate and mild complications accounted for 34.33%, 26.87% and 28.86%, respectively. Logistic regression analysis showed that congestive heart failure, diabetes mellitus (without complications) and nephropathy were independent influencing factors of in-hospital death in AMI patients; congestive heart failure, chronic lung disease and nephropathy were independent influencing factors of long-term hospitalization in AMI patients.Conclusion Charlson comorbidity index has an effect on in-hospital death and long-term hospitalization in patients with AMI, and it is feasible to evaluate different comorbidities by CCI score.

参考文献/References:

[1]姚媛英,陈珍初,丁光霞,等.基于住院病案首页肿瘤内科住院患者数据分析[J].中国病案,2020,21(8):57-60. [2]陈宇邦.住院病案首页数据挖掘和统计分析服务医院管理的研究[J].医学信息,2020,33(1):17-18. [3]齐向秀.急性心肌梗死患者住院期间死亡危险因素分析[J].中国病案,2020,21(5):109-112. [4]刘荃乐,梁国荣,陈百坚,等.建立胸痛中心对急性心肌梗死病人诊疗时效及住院时间的影响[J].中西医结合心脑血管病杂志,2021,19(23):4117-4119. [5]廖双华,郑文武,刘盼,等. 579例急性心肌梗死患者临床特点分析[J].西南军医,2018,20(1):64-67.[6]王妮,黄艳群,费晓璐,等.基于住院病案首页的Charlson合并症与脑卒中患者院内死亡的关系分析[J].中国卫生质量管理,2018,25(3):20-23.[7]叶渊文,潘琴,李飞飞,等.年龄校正Charlson合并症指数评估基础疾病对脓毒症患者院内死亡风险的影响[J].浙江医学,2022,44(16):1773-1776. [8]潘东峰,张永华.Charlson合并症指数对服毒症患者院内死亡风险预测价值研究[J].宁夏医学杂志,2019,41(12):1089-1091. [9]王合荣,于洪志,李莉,等.COVID-19轻症转重症的危险因素及年龄校正Charlson合并症指数对其的预测价值[J].山东医药,2021,61(5):5-8. [10]杨灵,王志聪,陈曦,等.891例老年髋部骨折患者合并基础疾病的特点及Charlson合并症指数对预后的影响[J].山东医药,2022,62(2):67-70. [11]刘晓芳,张冬梅.临床护理路径在急性心肌梗死急救中的效果观察及护理满意度的影响[J].河北医学,2016,22(4):670-673. [12]张依群.早期康复护理对急性心肌梗死患者生活质量和对医护满意度的影响[J].心血管康复医学杂志,2014(4):466-468.[13]王培文,李毅中,庄华烽,等.Charlson合并症评分对脆性髋部骨折患者死亡率的影响[J].中国骨质疏松杂志,2020,26(7):1005-1008. [14]冒智蕴,徐丹,邱旭升.Charlson指数对多发性骨髓瘤老年病人的预后评估价值[J].安徽医药,2020,24(1):115-118. [15]Demircan NC,Alan ?魻,Baｓoｇlu Tüylü T,et al.Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanib[J]. Journal of Oncology Pharmacy Practice,2020,26(5):1147-1155. [16]皮春梅,刘妍,崔北辰,等.急诊老年血流感染患者死亡危险因素分析[J].中国医药,2022,17(8):1211-1215.[17]张倩,李晶华,马天娇,等.Charlson合并症指数对COPD患者住院时间、住院费用及院内死亡的影响[J].医学与社会,2021,34(8):73-78. [18]程兆辉,贺知菲,陶红兵,等.山西省急性心肌梗塞患者院内死亡影响因素的多水平模型分析[J].医学与社会,2018,31(9):42-44,62.[19]Shebeshi DS,Dolja-Gore X,Byles J.Charlson Comorbidity Index as a predictor of repeated hospital admission and mortality among older women diagnosed with cardiovascular disease[J]. Aging Clinical and Experimental Research,2021,33(10):2873-2878.[20]吕俊兴,许海燕,杨跃进,等.中国急性心肌梗死患者住院时间及其延长的影响因素分析[J].临床心血管病杂志,2020,36(10):890-894.

相似文献/References:

[1]郭建华.丹参川芎嗪联合阿托伐他汀钙治疗急性心肌梗死的疗效观察[J].医学信息,2018,31(01):145.[doi:10.3969/j.issn.1006-1959.2018.01.056]
　GUO Jian-hua.Effect of Salvia Miltiorrhiza Tetramethylpyrazine Combined with Atorvastatin Calcium in the Treatment of Acute Myocardial Infarction[J].Journal of Medical Information,2018,31(22):145.[doi:10.3969/j.issn.1006-1959.2018.01.056]
[2]余湘宁,赵献明.ECMO在危重症心脏疾病中的应用研究[J].医学信息,2018,31(04):38.[doi:10.3969/j.issn.1006-1959.2018.04.013]
　YU Xiang-ning,ZHAO Xian-ming.Study on the Application of ECMO in Critical Heart Disease[J].Journal of Medical Information,2018,31(22):38.[doi:10.3969/j.issn.1006-1959.2018.04.013]
[3]毛红岩,宁国贤.冠脉介入治疗对冠心病急性心肌梗死患者 心肌损伤及心室重塑的影响[J].医学信息,2018,31(12):102.[doi:10.3969/j.issn.1006-1959.2018.12.031]
　MAO Hong-yan,NING Guo-xian.Effects of Coronary Intervention on Myocardial Injury and Ventricular Remodeling in Patients with Coronary Heart Disease and Acute Myocardial Infarction[J].Journal of Medical Information,2018,31(22):102.[doi:10.3969/j.issn.1006-1959.2018.12.031]
[4]雷 锐,李 志.冠状动脉介入及替罗非班治疗老年急性心肌梗死并 心源性休克的疗效分析[J].医学信息,2018,31(14):150.[doi:10.3969/j.issn.1006-1959.2018.14.046]
　LEI Rui,LI Zhi.Effect of Coronary Intervention and Tirofiban on Elderly Patients with Acute Myocardial Infarction and Cardiogenic Shock[J].Journal of Medical Information,2018,31(22):150.[doi:10.3969/j.issn.1006-1959.2018.14.046]
[5]高 珍,刘重斌,张菊英.氧疗对急性心肌梗死患者预后的影响[J].医学信息,2018,31(18):29.[doi:10.3969/j.issn.1006-1959.2018.18.011]
　GAO Zhen,LIU Chong-bin,ZHANG Ju-ying.Effect of Oxygenic Therapy on Prognosis of Patients with Acute Myocardial Infarction[J].Journal of Medical Information,2018,31(22):29.[doi:10.3969/j.issn.1006-1959.2018.18.011]
[6]韩 宇,朱丽丽,孙 婷,等.急性心肌梗死患者排便意愿的调查研究[J].医学信息,2018,31(20):111.[doi:10.3969/j.issn.1006-1959.2018.20.033]
　HAN Yu,ZHU Li-li,SUN Ting,et al.Investigation of Defecation Intention in Patients with Acute Myocardial Infarction[J].Journal of Medical Information,2018,31(22):111.[doi:10.3969/j.issn.1006-1959.2018.20.033]
[7]陈笑玲.急救护理流程再造在急性心肌梗死急诊介入治疗中的作用观察[J].医学信息,2018,31(23):168.[doi:10.3969/j.issn.1006-1959.2018.23.049]
　CHEN Xiao-ling.Effect of Emergency Nursing Process Reengineering on Emergency Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Journal of Medical Information,2018,31(22):168.[doi:10.3969/j.issn.1006-1959.2018.23.049]
[8]高 鹏,林文华,敬 锐,等.红细胞压积变化对急性ST段抬高型心肌梗死患者临床预后的影响[J].医学信息,2019,32(03):78.[doi:10.3969/j.issn.1006-1959.2019.03.024]
　GAO Peng,LIN Wen-hua,JING Rui,et al.Effect of Hematocrit Changes on Clinical Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction[J].Journal of Medical Information,2019,32(22):78.[doi:10.3969/j.issn.1006-1959.2019.03.024]
[9]杨 震.急性心梗直接介入治疗术中慢血流及无复流的治疗进展[J].医学信息,2019,32(06):56.[doi:10.3969/j.issn.1006-1959.2019.06.19]
　YANG Zhen.Progress in the Treatment of Slow Blood Flow and no Reflow in the Treatment of Acute Myocardial Infarction[J].Journal of Medical Information,2019,32(22):56.[doi:10.3969/j.issn.1006-1959.2019.06.19]
[10]杜 敏.肌红蛋白联合肌钙蛋白检测在急性心肌梗死早期诊断中的应用价值分析[J].医学信息,2019,32(08):180.[doi:10.3969/j.issn.1006-1959.2019.08.058]
　DU Min.Application Value of Myoglobin Combined with Troponin Detection in Early Diagnosis of Acute Myocardial Infarction[J].Journal of Medical Information,2019,32(22):180.[doi:10.3969/j.issn.1006-1959.2019.08.058]

更新日期/Last Update: 1900-01-01